Counsel patients regarding the potential threat for MTC with using tirzepatide and inform them of symptoms of thyroid tumors (e.g., a mass during the neck, dysphagia, dyspnea, persistent hoarseness). Schedule checking of serum calcitonin or applying thyroid ultrasound is of uncertain benefit for early detection of MTC in clients addressed with tirz